ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilization.
Publication/Presentation Date
4-1-2020
Abstract
Cardiac amyloidosis is emerging as an underdiagnosed cause of heart failure and mortality. Growing literature suggests that a noninvasive diagnosis of cardiac amyloidosis is now feasible. However, the diagnostic criteria and utilization of imaging in cardiac amyloidosis are not standardized. In this paper, Part 2 of a series, a panel of international experts from multiple societies define the diagnostic criteria for cardiac amyloidosis and appropriate utilization of echocardiography, cardiovascular magnetic resonance imaging, and radionuclide imaging in the evaluation of patients with known or suspected cardiac amyloidosis.
Volume
27
Issue
2
First Page
659
Last Page
673
ISSN
1532-6551
Published In/Presented At
Dorbala, Sharmila et al. “ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilization.” Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology vol. 27,2 (2020): 659-673. doi:10.1007/s12350-019-01761-5
Disciplines
Medicine and Health Sciences
PubMedID
31468377
Department(s)
Department of Medicine
Document Type
Article